Lars Thore Burgdorf,Norbert Beier,Johannes Gleitz,Christine Charon,Daniel Cravo
申请号：
US12682055
公开号：
US08420642B2
申请日:
2008.08.13
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Novel heterocyclic compounds of the formula Iin which R1, R2, R3, R4 and D have the meanings indicated in Claim 1, are activators of glucokinase and can be used for the prevention and/or treatment of Diabetes Typ 1 and 2, obesity, neuropathy and/or nephropathy.
